期刊文献+

ITP患者脾细胞分泌IL-18及IL-18结合蛋白的研究 被引量:6

Secretion of IL-18 and IL-18 Binding Protein from Splenocytes of ITP Patients In Vitro
暂未订购
导出
摘要 本研究旨在探讨特发性血小板减少性紫癜(ITP)脾脏单个核细胞培养后IL-18,IL-18结合蛋白(b ind ingprotein,BP),IFN-γ,IL-4等细胞因子的表达及其临床意义。常规无菌制备脾单个核细胞,置含PHA(phytohem agg lutinin)10μg/m l,10%胎牛血清的RPM I1640完全培养基中,于37℃、5%CO2条件下培养;分析ITP患者及正常对照者脾单个核细胞分泌细胞因子的差异。结果表明:脾单个核细胞培养48小时后,ITP患者IL-18和IFN-γ的含量较正常对照者明显升高;IL-18BP含量两组间差异无统计学意义(p=0.646);IL-4低于检测限。结论:IL-18、IL-18BP等细胞因子表达失衡在ITP的免疫紊乱和发生发展中起着一定的作用。 This study was aimed to investigate the expression and clinical significance of IL-18, IL-18 binding protein(IL-18BP), IFN-γ and IL-4 secreted from splenocytes of patients with idiopathic thrombocytopenic purpura (ITP) in vitro. Spleen mononuclear cells (MNC) were prepared by using routine sterile method, and were cultured in RPMI 1640 complete medium containing 10 μg/ml PHA, 10% fetal calf serum at 37℃ and 5% CO2. The levels of IFN-7, IL-4, IL-18 and IL-18BP secreted from MNC of ITP patients and normal controls were determined after culture for 48 hours. The results showed that after culture of spleen MNC for 48 hours, the levels of IL-18 and IFN-γ were significantly higher in patients with ITP than that in controls, but the levels of IL-18BP was not significantly elevated in ITP patients. The level of IL-4 was below the detectable limit of the assay used. It is concluded that imbalance between IL-18 and IL-18BP may play an important role in pathogenesis of ITP, and regulation of balance between IL-18 and IL- 18BP may be a therapeutic approach against ITP.
出处 《中国实验血液学杂志》 CAS CSCD 2011年第4期975-978,共4页 Journal of Experimental Hematology
基金 泰山学者基金,国家自然基金(编号0570779,30600259,30770922,30800491,30801258,30971278,81070396,81070408,81070407,81070411) 973计划(编号2011CB503906) 全国优秀博士论文基金(编号200561) 新世纪高校杰出人才基金(编号NCET-07-0514) 教育部重点项目(编号109097) 卫生部临床学科重点项目2010-2012 山东省自然基金(编号ZR2009CM001,ZR2010HQ002) 山东省临床医学中心基金 山东省医学领军人才基金 山东省优秀中青年科学家科研奖励基金(编号2008BSO3009) 山东大学自主创新基金(编号2009TS053)
关键词 特发性血小板减少性紫癜 白介素18 白介素18结合蛋白 idiopathic thrombocytopenic purpura intefleukin 18 interleukin 18 binding protein
  • 相关文献

参考文献11

  • 1Ogawara H, Handa H, Morita K, et al. High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol, 2003 ;71 (4) : 283 - 288.
  • 2Wang T, Zhao H, Ren H, et al. Type 1 and type 2 T-cell profiles in idiopathic thro mbocytopenic purpura. Haematologica, 2005;90 (7) :914 -923.
  • 3Olsson B, Andersson PO, Jem-s M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med,2003 ; 9 (9) : 1123 - 1124.
  • 4黄玉,李薇,杨波,朱宏丽,党艳辉.成人难治及复发ITP的个体化治疗及研究进展[J].中国实验血液学杂志,2009,17(6):1609-1615. 被引量:6
  • 5邱志勇,杨少光,陈振平,赵钦军,陈晓梨,周泽平,杨仁池,韩忠朝.脐带组织源间充质干细胞调控ITP患者脾细胞释放抗血小板抗体的体外研究[J].中国实验血液学杂志,2008,16(6):1372-1375. 被引量:6
  • 6Dameshek W, Miller EB. The megakaryocytes in idiopathic thromboeytopenic purpura, a form of hypersplenism. Blood, 1946; 1 : 27 - 52.
  • 7Rodeghiero F, Stasi R, Gemsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenie purpura of adults and children: report from an international working group. Blood, 2009 ; 113 ( 11 ) :2386 - 2393.
  • 8Shan NN, Zhu XJ, Wang Q, et al. High-dose dexamethasone regulates interleukin-18 and intedeukin-18 binding protein in idiopathic thrombocytopenic purpura. Haematologica, 2009 ; 94 (11) : 1603 -1607.
  • 9Shan NN, Zhu XJ, Peng J, et al. Interleukin 18 and interleukin 18 binding protein in patients with idiopathic thrombocytopenic purpura. Br J Haematol, 2009;144(5) :755 -761.
  • 10Ptaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST (c)) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res, 2002;30(9) :1 - 10.

二级参考文献58

  • 1刘爱国,杨默,李志光,黄伟哲,庞雅轩,李桂霞,胡群,伍百祥,霍泰辉.褪黑素对照射后小鼠血小板造血的保护作用[J].中华放射医学与防护杂志,2005,25(6):536-539. 被引量:5
  • 2范辉,朱宏丽,姚善谦,卢学春,庄晓萌,杨洋.氨磷汀治疗特发性血小板减少性紫癜高龄患者近期疗效观察[J].中国实验血液学杂志,2006,14(2):301-303. 被引量:16
  • 3张浪辉,刘拥军,吕璐璐,王爱萍,许贞书,朱雄鹏,陈志哲,韩忠朝.脐带源间充质干细胞对异源性脐带血T淋巴细胞激活与增殖的抑制作用[J].中国肿瘤生物治疗杂志,2006,13(3):191-195. 被引量:16
  • 4Rasmusson I. , Immune modulation by mesenchymal stem cells. Exp Cell Res, 2006 ; 312 : 2169 - 2179
  • 5Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 2007. 25 : 1384 - 1392
  • 6Cines DB, McMillan R. Pathogenesis of chronic immune thrombocytopenic purpura. Curr Opin Hematol, 2007 ; 14 : 511 - 514
  • 7Semple JW, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood, 1991. 78 : 2619 -2625
  • 8Corcione A, Benvenuto F, Ferretti E, et al. Human mesenchymal stem cells modulate B-cell functions. Blood, 2006; 107:367 -372
  • 9Comoli P, Ginevri F, Maccario R, et al. Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol Dial Transplant, 2007 ; 23 : 1196 - 1202
  • 10Traggiai E, Volpi S, Schena F, et al. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells, 2008 ; 26 : 562 - 569

共引文献10

同被引文献32

引证文献6

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部